In fact, the epigenetic regulation of FBLN2 with relation to tumor progression has been depicted in other types of human cancers, including childhood acute lymphoblastic leukemia [37] and colon [38], prostate, breast [26] and nasopharyngeal cancer [15]. Here, FBLN2 is linked to nasopharyngeal carcinoma.